Combined Therapy with Desferal and Deferioprone in Improvement of Heart Function in Thalassemic Patients

Abstract

Background: Cardiac complications due to iron overload are the most common causes of death in patients with major thalassemia. This study assessed the efficacy of iron chelating by desferal-L1 in improvement of cardiac function in patients with major thalassemia.